New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
Abstract Background A validated prognostic index for the outcome of patients with advanced high-grade serous ovarian cancer (HGSOC) undergoing neoadjuvant chemotherapy (NACT) remains elusive. To address this need, we developed an ovarian neoadjuvant chemotherapy prognostic index (ONCPI) to improve p...
Saved in:
| Main Authors: | Chuying Huo, Bin Wu, Dongdong Ye, Miaochun Xu, Shaolin Ma, Aoshuang Cheng, Yunyun Liu, Chunxian Huang, Yuhao Zhang, Zhongqiu Lin, Bowen Li, Huaiwu Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-13324-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histone deacetylase 6 and programmed death ligand-1 expressions after neoadjuvant chemotherapy are upregulated in patients with ovarian high-grade serous carcinoma
by: Mitsutake Yano, et al.
Published: (2025-06-01) -
Risk Factors for Recurrence in Serous Borderline Ovarian Tumors and Early-Stage Low-Grade Serous Ovarian Carcinoma
by: Jingjing Zhang, et al.
Published: (2025-04-01) -
NMR-based serum metabolomics in patients with low-differentiated serous ovarian cancer
by: Mateusz M. Klimek, et al.
Published: (2025-06-01) -
Radiologic and surgical peritoneal cancer index in patients with low grade serous ovarian carcinoma
by: Rachel R. Pacyna, et al.
Published: (2025-08-01) -
BCL6 promotes the progression of high-grade serous ovarian cancer cells by inhibiting PLAAT4
by: An Wan, et al.
Published: (2025-07-01)